Photo of Marc-Aurel Fuchs

Marc-Aurel Fuchs

Mr

20132017
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Marc-Aurel Fuchs is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 19 Similar Profiles
triclabendazole Medicine & Life Sciences
Colorectal Neoplasms Medicine & Life Sciences
Molecular Pathology Medicine & Life Sciences
Mutation Medicine & Life Sciences
Fasciola hepatica Medicine & Life Sciences
Microsatellite Instability Medicine & Life Sciences
Mitogen-Activated Protein Kinase Kinases Medicine & Life Sciences
DNA Methylation Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2013 2017

  • 4 Article
  • 2 Conference contribution
162 Downloads (Pure)

Molecular profiling of signet ring cell colorectal cancer provides a strong rationale for genomic targeted and immune checkpoint inhibitor therapies

Alvi, M., Loughrey, M. B., Dunne, P., McQuaid, S., Turkington, R., Fuchs, M-A., McGready, C., Bingham, V., Moore, W., Lawler, M., James, J. A., Murray, G. I., Wilson, R. H., Maxwell, P. & Salto-Tellez, M., 11 Jul 2017, In : British Journal of Cancer. 117, 2, p. 203-209

Research output: Contribution to journalArticle

Open Access
File
Microsatellite Instability
Colorectal Neoplasms
CpG Islands
Phenotype
Genotype
4 Citations (Scopus)

Natural killer-like signature observed post therapy in locally advanced rectal cancer is a determinant of pathological response and improved survival

Alderdice, M., Dunne, P. D., Cole, A. J., O'Reilly, P. G., McArt, D. G., Bingham, V., Fuchs, M-A., McQuaid, S., Loughrey, M. B., Graeme, M. I., Samuel, L. M., Lawler, M., Wilson, R. H., Salto-Tellez, M. & Coyle, V. M., 16 Jun 2017, In : Modern Pathology .

Research output: Contribution to journalArticle

Open Access
Rectal Neoplasms
Chemoradiotherapy
Survival
Neoplasms
Natural Killer Cells

ADAM17: a potential regulator of resistance to EGFR targeted therapies in RAS wild type colorectal cancer.

Weir, J-A., Gilliland, P., Fuchs, M-A., Williams, R., Murray, L., Johnston, P. & Van Schaeybroeck, S., Nov 2016, ADAM17: a potential regulator of resistance to EGFR targeted therapies in RAS wild type colorectal cancer.. National Cancer Research Institute

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Colorectal Neoplasms
Therapeutics
Ligands
ADAM17 Protein
Cetuximab

Validation of a MEK/MET-specific NGS panel for early phase trial interrogation

Maxwell, P., del favero, J., Fuchs, M-A., Tabernero, J., Maughan, T., Middleton, M., Adams, R., Rolfo, C., Hennessy, B. T., Laurent=puig, P., Bardelli, A., Andre, T., Popovici, V., Johnston, P., Wilson, R., Lawler, M., Van Schaeybroeck, S. & Salto-Tellez, M., 01 May 2016, Validation of a MEK/MET-specific NGS panel for early phase trial interrogation . Proceedings: AACR Annual Meeting 2016; April 16-20 New Orleans, Vol. abstract 1396.

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Mitogen-Activated Protein Kinase Kinases
Computational Biology
Exons
Mutation
Genes
17 Citations (Scopus)
189 Downloads (Pure)

Comprehensive molecular pathology analysis of small bowel adenocarcinoma reveals novel targets with potential for clinical utility

Alvi, M. A., McArt, D. G., Kelly, P., Fuchs, M-A., Alderdice, M., McCabe, C. M., Bingham, V., McGready, C., Tripathi, S., Emmert-Streib, F., Loughrey, M. B., McQuaid, S., Maxwell, P., Hamilton, P. W., Turkington, R., James, J. A., Wilson, R. H. & Salto-Tellez, M., 30 Jul 2015, In : Oncotarget. 6, 25, p. 20863-74 12 p.

Research output: Contribution to journalArticle

Open Access
File
Molecular Pathology
DNA Methylation
Gene Expression
Adenocarcinoma
Mutation